Form 4: Evommune CEO Receives Stock Grant
Insider Transaction (Form 4)
Luis C. Pena, President & CEO and a Director of Evommune, Inc., received 1,115 shares of common stock on September 30, 2026.
Summary
- Grant/award: acquired 1,115 Common Stock at $7.02 ($7,827) on September 30, 2026; holds 631,573 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Luis C. Pena — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant/award | Common Stock | 1,115 | $7 | $7.8K | 631,573 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Grant/award (1,115 shares) |
Keywords
insider transaction, Form 4, EVMN, Evommune, Inc., neutral, Luis C. Pena
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.